Skip to content

Checked

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

NCT07023289 on ClinicalTrials.gov

Study listings come from ClinicalTrials.gov, where sponsors register and update their own studies. A listing does not mean a study is safe or effective, and DatenUS does not recommend any study. Talk with your doctor before joining a clinical trial, and use ClinicalTrials.gov for contact details and full eligibility rules.

Status
Recruiting
Phase
Phase 2
Interventional
Planned enrollment
140
Participants, all sites
U.S. sites
22
In 15 states

Study details

Conditions
Colorectal Cancer
Sponsor
AbbVie (Industry)
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Start
09/02/2025
Primary completion (expected)
November 2029
Last updated by sponsor
10/09/2026

Full eligibility rules, contacts and site names: NCT07023289 on ClinicalTrials.gov

Where the study has sites

Cities with at least one listed U.S. site. Some sites may not be enrolling yet.

  • Alabama: Huntsville
  • California: Fullerton, Los Angeles
  • Florida: Jacksonville, Tampa
  • Illinois: Chicago
  • Maryland: Baltimore
  • Massachusetts: Boston
  • Michigan: Ann Arbor
  • Minnesota: Minneapolis, Rochester
  • New York: Lake Success
  • North Carolina: Durham
  • Oregon: Portland
  • Pennsylvania: Philadelphia
  • Tennessee: Nashville
  • Texas: Austin, Fort Worth, Grapevine, Houston
  • Virginia: Fairfax (2)

More studies on the same topic

Frequently asked questions

What does recruiting mean?
Recruiting means the study is currently enrolling participants. Not yet recruiting means it has been registered but has not started enrolling. Enrolling by invitation means participants are selected by the study team rather than through open enrollment.
How do I join a clinical trial?
Read the full eligibility criteria and contact information on ClinicalTrials.gov, then talk with your doctor about whether a study may be right for you. The study team decides who can enroll.

Source: ClinicalTrials.gov, National Library of Medicine · Last updated 10/09/2026